These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36862544)

  • 41. Occurrence of antimicrobial resistant bacteria in healthy dogs and cats presented to private veterinary hospitals in southern Ontario: A preliminary study.
    Murphy C; Reid-Smith RJ; Prescott JF; Bonnett BN; Poppe C; Boerlin P; Weese JS; Janecko N; McEwen SA
    Can Vet J; 2009 Oct; 50(10):1047-53. PubMed ID: 20046603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of antimicrobial resistance and multidrug resistance among bacterial isolates from diseased pets: Retrospective laboratory data (2015-2017).
    Haulisah NA; Hassan L; Jajere SM; Ahmad NI; Bejo SK
    PLoS One; 2022; 17(12):e0277664. PubMed ID: 36477195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro susceptibility of canine and feline Escherichia coli to fosfomycin.
    Hubka P; Boothe DM
    Vet Microbiol; 2011 Apr; 149(1-2):277-82. PubMed ID: 21168287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of bacterial uropathogens and their antimicrobial susceptibility patterns among pregnant women in Eastern Ethiopia: hospital-based cross-sectional study.
    Ejerssa AW; Gadisa DA; Orjino TA
    BMC Womens Health; 2021 Aug; 21(1):291. PubMed ID: 34364376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus pseudintermedius isolated from various animals.
    Rubin JE; Ball KR; Chirino-Trejo M
    Can Vet J; 2011 Feb; 52(2):153-7. PubMed ID: 21532820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancing the empiric antibiotic selection by introducing an antibiogram toolkit in a tertiary care hospital in Southern India - A prospective study.
    Krishnamoorthy SG; Raj V; Viswanathan B; Dhanasekaran GP; Palaniappan D; Borra SS
    J Clin Pharm Ther; 2022 Apr; 47(4):507-516. PubMed ID: 34962298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report.
    Veeraraghavan B; Jesudason MR; Prakasah JAJ; Anandan S; Sahni RD; Pragasam AK; Bakthavatchalam YD; Selvakumar RJ; Dhole TN; Rodrigues C; Roy I; Joshi S; Chaudhuri BN; Chitnis DS
    Indian J Med Microbiol; 2018; 36(1):32-36. PubMed ID: 29735823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of susceptibility test breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs.
    Bemis DA; Jones RD; Frank LA; Kania SA
    J Vet Diagn Invest; 2009 Jan; 21(1):53-8. PubMed ID: 19139501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of cumulative antibiogram reports in intensive care units at an Egyptian University Hospital.
    Negm EM; Elgharabawy ES; Badran SG; Soliman AM; El Sayed AM; Raafat AON; Soliman ST; Mahmoud HM; Tawfik AE; El Hawary AT; El Hawary A; Elhewala A; El-Sokkary RH
    J Infect Public Health; 2023 Aug; 16(8):1220-1229. PubMed ID: 37276716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
    Akgül Ö; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):404-417. PubMed ID: 32755517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of bacterial growth and antimicrobial susceptibility patterns in canine urinary tract infections.
    Windahl U; Holst BS; Nyman A; Grönlund U; Bengtsson B
    BMC Vet Res; 2014 Sep; 10():217. PubMed ID: 25249356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.
    Valentine BK; Dew W; Yu A; Weese JS
    Vet Dermatol; 2012 Dec; 23(6):493-e95. PubMed ID: 23050904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial resistance in coagulase-positive staphylococci isolated from companion animals in Australia: A one year study.
    Saputra S; Jordan D; Worthing KA; Norris JM; Wong HS; Abraham R; Trott DJ; Abraham S
    PLoS One; 2017; 12(4):e0176379. PubMed ID: 28430811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial resistance patterns of bacteria isolated from canine urinary samples submitted to a New Zealand veterinary diagnostic laboratory between 2005-2012.
    McMeekin CH; Hill KE; Gibson IR; Bridges JP; Benschop J
    N Z Vet J; 2017 Mar; 65(2):99-104. PubMed ID: 27842208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cephalexin susceptibility breakpoint for veterinary isolates: Clinical Laboratory Standards Institute revision.
    Papich MG; Lindeman C
    J Vet Diagn Invest; 2018 Jan; 30(1):113-120. PubMed ID: 29145786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibacterial activity of chemotherapeutic drugs against Escherichia coli and Staphylococcus pseudintermedius.
    Campbell O; Gagnon J; Rubin JE
    Lett Appl Microbiol; 2019 Nov; 69(5):353-357. PubMed ID: 31508840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.